TCL Archive NCAB Disproves W. Virginia Construction Grant, Okays Funding Three New, Three Carryover Awards May 24, 1985
TCL Archive Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named. March 24, 2006
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated November 28, 1975
